Detalles de la búsqueda
1.
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Lancet
; 401(10374): 347-356, 2023 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36739136
2.
The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity.
Hum Genomics
; 17(1): 99, 2023 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37946254
3.
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method.
Ther Drug Monit
; 2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38366332
4.
Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study.
Pharmacol Res
; 197: 106949, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37802427
5.
Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?
Br J Clin Pharmacol
; 2023 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37926674
6.
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients.
Br J Clin Pharmacol
; 89(3): 1089-1098, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36178950
7.
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis.
Int J Mol Sci
; 24(4)2023 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36834713
8.
Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity.
Am J Hum Genet
; 104(6): 1158-1168, 2019 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31155283
9.
European association for clinical pharmacology and therapeutics young clinical pharmacologists working group: a cornerstone for the brighter future of clinical pharmacology.
Eur J Clin Pharmacol
; 78(4): 691-694, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35037981
10.
A TGF-ß associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer.
Gynecol Oncol
; 156(1): 233-242, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31711657
11.
CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions.
Int J Mol Sci
; 21(17)2020 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32883002
12.
Body mass index impacts adverse events and drug plasma concentration: should dose intensity be included in the palbociclib equation?
Breast Cancer Res Treat
; 203(1): 183-184, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37804389
13.
Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS).
Int J Mol Sci
; 19(5)2018 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29783665
14.
Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment.
Int J Mol Sci
; 18(7)2017 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-28708103
15.
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines.
Int J Cancer
; 137(12): 2971-80, 2015 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26099996
16.
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways.
Crit Rev Oncol Hematol
; 199: 104379, 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38718940
17.
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.
Pharmaceutics
; 15(5)2023 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37242766
18.
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.
Daru
; 31(2): 267-272, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37318715
19.
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure.
Biomed Pharmacother
; 164: 114906, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37295250
20.
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer.
Biomed Pharmacother
; 167: 115479, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734262